title: Chickenpox party or varicella vaccine?
abstract: The most compelling rationale for introducing universal vaccination against varicella was the predicted benefits to healthy children. Current evidence from the US experience indicates that these benefits are being realized. As is true for any new vaccine, implementation of such a program necessitates disease surveillance and modifications of the vaccine regimen as needed. In the case of VZV, the epidemiology of herpes zoster must be tracked as well as varicella disease trends. The prevention of herpes zoster may be another use of live attenuated or inactivated varicella vaccines.
authors.affiliation: Columbia University, Department of Pediatrics, New York, NY 10032, USA.
authors.forename: Sophie
authors.initials: S
authors.lastname: Hambleton
authors.forename: Ann M
authors.initials: AM
authors.lastname: Arvin
mesh_terms: D002644:Chickenpox / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D019433:Chickenpox Vaccine / Q000191:economics / Q000627:therapeutic use*; D006562:Herpes Zoster / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D014481:United States / Q000453:epidemiology; D014611:Vaccination; D014613:Vaccines, Attenuated / Q000191:economics / Q000627:therapeutic use; D017735:Virus Latency
chemical_list: D019433:Chickenpox Vaccine; D014613:Vaccines, Attenuated